Karakatsanis, Andreas
Eriksson, Staffan
Pistiolis, Lida
Olofsson Bagge, Roger
Nagy, Gyula
Man, Vivian
Kwong, Ava
Wärnberg, Fredrik
Mohammed, Imad
Hersi, Abdi Fatah
Jazrawi, Allan
Olofsson, Helena
Stålberg, Peter
,
Funding for this research was provided by:
Landstinget i Uppsala län
Bröstcancerförbundet
Uppsala University
Article History
Received: 1 November 2021
Accepted: 22 December 2022
First Online: 31 January 2023
Disclosure
: ROB has received institutional research grants from Bristol-Myers Squibb (BMS) and SkyLineDx, speaker honorarium from Roche and Pfizer and has served on advisory boards for Amgen, BD/BARD, Bristol-Myers Squibb (BMS), Merck Sharp & Dohme (MSD), Novartis, Roche and Sanofi Genzyme. All other authors declare no conflicts of interest.